Time-points for minimal residual disease monitoring in patients with acute myeloid leukemia who underwent allogeneic stem cells transplantation: a comparison between multiparameter flow cytometry and Wilm's tumor 1 expression

被引:0
作者
Rossi, G. [1 ]
Carella, A. M. [1 ]
Minervini, M. M. [1 ]
di Nardo, F. [2 ]
Greco, M. M. [1 ]
Meria, E. [1 ]
Savino, L. [1 ]
de Gills, G. P. [1 ]
Di Renzo, N. [3 ]
Melpignano, A. [4 ]
Capalbo, S. [5 ]
Pisapia, G. [6 ]
Cascavilla, N. [1 ]
机构
[1] IRCCS Casa Sollievo Sofferenza, Dept Hematol, San Giovanni Rotondo, Italy
[2] Univ Cattolica Sacro Cuore, Dept Hyg, I-00168 Rome, Italy
[3] Vito Fazzi Hosp, Dept Hematol, Lecce, Italy
[4] Perrino Hosp, Dept Hematol, Brindisi, Italy
[5] Riuniti Hosp, Dept Hematol, Foggia, Italy
[6] San Giuseppe Moscati Hosp, Dept Hematol, Taranto, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P244
引用
收藏
页码:S239 / S239
页数:1
相关论文
共 50 条
[21]   Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation [J].
Bastos-Oreiro, Mariana ;
Perez-Corral, Ana ;
Martinez-Laperche, Carolina ;
Bento, Leyre ;
Pascual, Cristina ;
Kwon, Mi ;
Balsalobre, Pascual ;
Munoz, Cristina ;
Buces, Elena ;
Serrano, David ;
Gayoso, Jorge ;
Buno, Ismael ;
Anguita, Javier ;
Luis Diez-Martin, Jose .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (03) :239-246
[22]   Pretransplantation minimal residual disease monitoring by multiparameter flow cytometry predicts outcomes of AML patients receiving allogeneic hematopoietic stem cell transplantation [J].
Zhang, Yun ;
Wang, Ping ;
Cassady, Kaniel ;
Zou, Zhongmin ;
Li, Yi ;
Deng, Xiaojuan ;
Yang, Wuchen ;
Peng, Xiangui ;
Zhang, Xi ;
Feng, Yimei .
TRANSPLANT IMMUNOLOGY, 2022, 72
[23]   Determination of minimal residual disease in patients with acute myeloid leukemia by multiparameter flow cytometry: Prognostic impact at different checkpoints [J].
Kern, W ;
Voskova, D ;
Schoch, C ;
Hiddemann, W ;
Schnittger, S ;
Haferlach, T .
BLOOD, 2004, 104 (11) :117A-117A
[24]   Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia [J].
Ravandi, Farhad ;
Jorgensen, Jeffrey ;
Borthakur, Gautam ;
Jabbour, Elias ;
Kadia, Tapan ;
Pierce, Sherry ;
Brandt, Mark ;
Wang, Sa ;
Konoplev, Sergej ;
Wang, Xuemei ;
Huang, Xuelin ;
Daver, Naval ;
DiNardo, Courtney ;
Andreeff, Michael ;
Konopleva, Marina ;
Estrov, Zeev ;
Garcia-Manero, Guillermo ;
Cortes, Jorge ;
Kantarjian, Hagop .
CANCER, 2017, 123 (03) :426-435
[25]   Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation [J].
Giannoni, Livia ;
Guolo, Fabio ;
Minetto, Paola ;
Galaverna, Federica ;
Ghiggi, Chiara ;
Clavio, Marino ;
Bagnasco, Samuele ;
Di Grazia, Carmen ;
Grasso, Raffaella ;
Colombo, Nicoletta ;
Avenoso, Daniele ;
Pastori, Giordana ;
Ballerini, Filippo ;
Kunkl, Annalisa ;
Miglino, Maurizio ;
Lemoli, Roberto ;
Gobbi, Marco ;
Bacigalupo, Andrea .
BLOOD, 2014, 124 (21)
[26]   MINIMAL RESIDUAL DISEASE BY WT1 GENE EXPRESSION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER INDUCTION AND CONSOLIDATION CHEMOTHERAPY: CORRELATION WITH MULTIPARAMETER FLOW CYTOMETRY [J].
Franco, A. ;
Kwon, M. ;
Martinez-Laperche, C. ;
Balsalobre, P. ;
Font, P. ;
Encinas, C. ;
Escudero, A. ;
Gayoso, J. ;
Anguita, J. ;
Diez-Martin, J. ;
Buno, I. .
HAEMATOLOGICA, 2013, 98 :283-283
[27]   Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation [J].
H Tamaki ;
H Ogawa .
Bone Marrow Transplantation, 2004, 34 :653-654
[28]   Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation [J].
Tamaki, H ;
Ogawa, H .
BONE MARROW TRANSPLANTATION, 2004, 34 (07) :653-654
[29]   PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE BEFORE ALLOGENEIC MARROW TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA BY COMBINEDWT1 EXPRESSION LEVELS AND FLOW CYTOMETRY ASSESMENT [J].
Guolo, F. ;
Minetto, P. ;
Galaverna, F. ;
Giannoni, L. ;
Ghiggi, C. ;
Clavio, M. ;
Beltrami, G. ;
Ibatici, A. ;
Di Grazia, C. ;
Raiola, A. M. ;
Mitscheunig, L. ;
Grasso, R. ;
Colombo, N. ;
De Astis, E. ;
Avenoso, D. ;
Cruciani, F. ;
Lovera, D. ;
Pastori, G. ;
Ballerini, F. ;
Aquino, S. ;
Kunkl, A. ;
Miglino, M. ;
Lemoli, R. M. ;
Gobbi, M. ;
Carella, A. M. ;
Bacigalupo, A. .
HAEMATOLOGICA, 2014, 99 :301-301
[30]   Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia [J].
Miyazaki, Takuya ;
Fujita, Hiroyuki ;
Fujimaki, Katsumichi ;
Hosoyama, Takeshi ;
Watanabe, Reina ;
Tachibana, Takayoshi ;
Fujita, Atsuko ;
Matsumoto, Kenji ;
Tanaka, Masatsugu ;
Koharazawa, Hideyuki ;
Taguchi, Jun ;
Tomita, Naoto ;
Sakai, Rika ;
Fujisawa, Shin ;
Kanamori, Heiwa ;
Ishigatsubo, Yoshiaki .
LEUKEMIA RESEARCH, 2012, 36 (08) :998-1003